Fig. 1
From: Recurrent late-onset neutropenia after ofatumumab treatment in a case of multiple sclerosis
Overview of immune cell counts. The graph displays counts of lymphocytes, neutrophils, and B cells before, during and after the OFA treatment
Fig. 1 | Neurological Research and Practice